M&T Bank’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
M&T Bank's IBB Position: Q2 2026 in Review
M&T Bank increased its iShares Biotechnology ETF (IBB) stake by 6.4% in Q2 2026, buying an estimated $20.6K and bringing the position to 1,990 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.
M&T Bank first reported a position in IBB in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.52M in Q3 2022. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- M&T Bank held 1,990 shares of iShares Biotechnology ETF worth $378K as of Q2 2026.
- M&T Bank bought 120 iShares Biotechnology ETF shares in Q2 2026, an estimated $20.6K.
- iShares Biotechnology ETF made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1341 holding.
- M&T Bank first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 47 quarters since.
- M&T Bank's iShares Biotechnology ETF position peaked at $2.52M in Q3 2022.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.